ImmunityBio, Inc. IBRX Capital investments accrued but not yet paid
Capital investments accrued but not yet paid at other companies
Other financials
Where this comes from
Reported directly by ImmunityBio, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CapitalExpendituresIncurredButNotYetPaid.
The official record: ImmunityBio, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about ImmunityBio, Inc.'s capital investments accrued but not yet paid.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is ImmunityBio, Inc.'s capital investments accrued but not yet paid?
- ImmunityBio, Inc. (IBRX) reported capital investments accrued but not yet paid of $1.41M in Q1 2026.
- How has ImmunityBio, Inc.'s capital investments accrued but not yet paid changed year-over-year?
- ImmunityBio, Inc.'s capital investments accrued but not yet paid increased by 27.0% year-over-year, from $1.11M to $1.41M.